Rankings
▼
Calendar
NVAX
Novavax, Inc.
$2B
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$5M
Gross Profit
-$46M
-846.5% margin
Operating Income
-$54M
-1001.0% margin
Net Income
-$57M
-1057.8% margin
EPS (Diluted)
$-4.21
QoQ Revenue Growth
+67.1%
Cash Flow
Operating Cash Flow
-$61M
Free Cash Flow
-$64M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$394M
Total Liabilities
$400M
Stockholders' Equity
-$6M
Cash & Equivalents
$144M
← FY 2016
All Quarters
Q1 2017 →
NVAX Q4 2016 Earnings — Novavax, Inc. Revenue & Financial Results | Market Cap Arena